Prospective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high-risk women

BMC Women's Health

Volumn 6, Issue , 2006, Pages

  Rubinstein, Wendy S ^a,b   Latimer, Jean J ^c,d,e   Sumkin, Jules H ^d   Huerbin, Michelle ^d   Grant, Stephen G ^c,d,e,f   Vogel, Victor G ^c,d,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GADOLINIUM;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE MUTATION; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; PILOT STUDY; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

EID: 33748053964     PISSN: 14726874     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-6-10     Document Type: Article

References (65)

1. Burhenne HJ, Burhenne LW, Goldberg F, Hislop TG, Worth AJ, Rebbeck PM, Kan L: Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification. Am J Roentgenol 1994, 162:1067-1071. discussion 162:1072-1075.
2. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V: Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. JAMA 1996, 276:39-43.
3. Robertson CL: A private breast imaging practice: medical audit of 25,788 screening and 1,077 diagnostic examinations. Radiology 1993, 187:75-79.
4. Humphrey LL, Helfand M, Chan BK, Woolf SH: Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002, 137:347-360.
5. Wolfe JN: Breast parenchymal patterns and their changes with age. Radiology 1976, 121:545-552.
6. Brisson J, Sadowsky NL, Twaddle JA, Morrison AS, Cole P, Merletti F: The relation of mammographic features of the breast to breast cancer risk factors. Am J Epidemiol 1982, 115:438-443.
7. Gram IT, Funkhouser E, Tabar L: Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women. Br J Cancer 1995, 71:647-650.
8. Oza AM, Boyd NF: Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 1993, 15:196-208.
9. Tabar L, Dean PB: Mammographic parenchymal patterns. Risk indicator for breast cancer? JAMA 1982, 247:185-189.
10. Byng JW, Yaffe MJ, Jong RA, Shumak RS, Lockwood GA, Tritchler DL, Boyd NF: Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 1998, 18:1587-1598.
11. Harvey JA, Bovbjerg VE: Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 2004, 230:29-41.
12. Jackson VP, Hendrick RE, Feig SA, Kopans DB: Imaging of the radiographically dense breast. Radiology 1993, 188:297-301.
13. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E: Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000, 92:1081-1087.
14. Peto J, Mack TM: High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 2000, 25:411-414.
15. Ponder BAJ, Day NE, Easton DF, Pharoah PDP, Anglian Breast Cancer Study Group: Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 2000, 83:1301-1308.
16. Easton DF, Narod SA, Ford D, Steel M: The genetic epidemiology of BRCA1. Breast Cancer Linkage Consortium. Lancet 1994, 344:761.
17. Lynch HT, Lynch JF, Rubinstein WS: Prophylactic mastectomy: obstacles and benefits. J Natl Cancer Inst 2001, 93:1586-1587.
18. Helvie MA, Roubidoux MA, Weber BL, Merajver SD: Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: initial experience. Am J Roentgenol 1997, 168:1599-1602.
19. Huo Z, Giger ML, Olopade OI, Wolverton DE, Weber BL, Metz CE, Zhong W, Cummings SA: Computerized Analysis of Digitized Mammograms of BRCA1 and BRCA2 Gene Mutation Carriers. Radiology 2002, 225:519-526.
20. Tilanus-Linthorst M, Verhoog L, Obdeijn IM, Bartels K, Menke-Pluymers M, Eggermont A, Klijn J, Meijers-Heijboer H, van der Kwast T, Brekelmans C: A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer 2002, 102:91-95.
21. Deng CX, Brodie SG: Roles of BRCA1 and its interacting proteins. BioEssays 2000, 22:728-737.
22. Jasin M: Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 2002, 21:8981-8993.
23. Rosen EM, Fan S, Pestell RG, Goldberg ID: BRCA1 gene in breast cancer. J Cell Physiol 2003, 196:19-41.
24. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV: MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993, 187:493-501.
25. Orel SG, Schnall MD, LiVolsi VA, Troupin RH: Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994, 190:485-493.
26. Davis PL, McCarty KS Jr: Sensitivity of enhanced MRI for the detection of breast cancer: new, multicentric, residual, and recurrent. Eur Radiol 1997, 7(Suppl 5):289-298.
27. Harms SE: MRI in breast cancer diagnosis and treatment. Curr Probl Diagn Radiol 1996, 25:193-215.
28. Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W: MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989, 171:95-103.
29. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, Muller SH, Meijer S, Oosterwijk JC, Beex LV, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG, Magnetic Resonance Imaging Screening Study Group: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004, 351:427-437.
30. Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004, 292:1317-1325.
31. American College of Radiology (ACR): BI-RADS (Breast Imaging Reporting and Data System) Atlas Reston, VA: American College of Radiology; 2003.
32. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886.
33. Parmigiani G, Berry D, Aguilar O: Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998, 62:145-158.
34. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS: Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999, 91:1541-1548.
35. Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 2002, 20:2701-2712.
36. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M, Breast Cancer Linkage Consortium: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998, 62:676-689.
37. Euhus DM: Understanding mathematical models for breast cancer risk assessment and counseling. Breast J 2001, 7:224-232.
38. CancerGene [http:/www4.utsouthwestern.edu/breasthealth/cagene]
39. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH: Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999, 211:101-110.
40. Hylton NM: Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn Reson Imag Clin N Am 1999, 9:411-420.
41. Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA, Weinreb JC, Smazal SF, Degani H, Viehweg P, Barclay J, Schnall MD: Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imag 2001, 13:889-895.
42. Schnall MD, Ikeda DM, Lesion Diagnosis Working Group: Lesion Diagnosis Working Group Report. J Magn Reson Imag 1999, 10:982-990.
43. Hylton N, Dedicated Breast MRI Systems Working Group: Dedicated Breast MRI Systems Working Group Report. J Magn Reson Imag 1999, 10:1006-1009.
44. Latimer JJ, Rubinstein WS, Johnson JM, Kanbour-Shakir A, Grant SG: Haploinsufficiency for BRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes. BMC Med Genet 2005, 6:26.
45. Robson ME, Offit K: Breast MRI for women with hereditary cancer risk. JAMA 2004, 292:1368-1370.
46. Kuhl CK, Kreft BP, Hauswirth A, Elevelt A, Steudel A, Reiser M, Schild HH: MR mammography at 0.5 tesla. I. Comparison of image quality and sensitivity of MR mammography at 0.5 and 1.5 T. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1995, 162:381-389. erratum 163:96
47. Kuhl CK, Kreft BP, Hauswirth A, Gieseke J, Elevelt A, Reiser M, Schild HH: MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1995, 162:482-491.
48. Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP 3rd, Foster RS Jr, Hendrick E, Eyre HJ, Sener S, American Cancer Society High-Risk Work Group, American Cancer Society Screening Older Women Work Group, American Cancer Society Mammography Work Group, American Cancer Society Physical Examination Work Group, American Cancer Society New Technologies Work Group, American Cancer Society Breast Cancer Advisory Group: American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003, 53:141-169.
49. Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C: Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 1997, 277:997-1003.
50. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Practice Guideline in Oncology version I. National Comprehensive Cancer Network [http://www.nccn.org]
51. Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N: Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002, 20:1260-1268.
52. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW: Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998, 338:1089-1096.
53. Harris R, Leininger L: Clinical strategies for breast cancer screening: weighing and using the evidence. Ann Intern Med 1995, 122:539-547.
54. Harris R: Variation of benefits and harms of breast cancer screening with age. J Natl Cancer Inst Monogr 1997:139-143.
55. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V: Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996, 276:33-38.
56. Kaiser WA, Zeitler E: MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 1989, 170:681-686.
57. Stoutjesdijk MJ, Boetes C, Jager GJ, Beex L, Bult P, Hendriks JH, Laheij RJ, Massuger L, van Die LE, Wobbes T, Barentsz JO: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001, 93:1095-1102.
58. Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaffe MJ, Goel V, Ramsay E, Chart PL, Cole DE, Taylor GA, Cutrara M: Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001, 19:3524-3531.
59. Sumkin JH, Ganott MA, Hakim CM, Hardesty LA, Poller WR, Rubinstein WS: MRI, ultrasound, and digital mammography for breast cancer screening in women at high risk [abstract]. American Roentgen Ray Society annual meeting, New Orleans. May 15-20, 2005
60. Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991, 48:232-242.
61. Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004, 23:1111-1130.
62. King M-C, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B: Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 2001, 286:2251-2256.
63. Vogel VG: High-risk populations as targets for breast cancer prevention trials. Prev Med 1991, 20:86-100.
64. Rubinstein WS, O'Neill SM, Peters JA, Rittmeyer LJ, Stadler MP: Mathematical modeling for breast cancer risk assessment. State of the art and role in medicine. Oncology 2002, 16:1082-1094. discussion 16:1094, 16:1097-1099
65. Lehman CD, Schnall MD, Kuhl CK, Harms SE: Report of the Working Groups on Breast MRI: report of the High-Risk Screening Group. Breast J 2004, 16(Suppl 2):S9-S12.